The cross-pollination of therapeutic concepts between different medical fields is a powerful engine for innovation (Table). This path is well-trodden; cornerstone therapies in rheumatology, such as methotrexate and rituximab, were first developed and utilized in oncology before finding profound success in treating autoimmune diseases.
A novel agent in t…
